/CANB
CANB Stock - Can B Corp.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.02+14.29%
+$0.00 (+14.29%) • Jan 12
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.14
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.86
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.02
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CANB
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.02 – $0.02
TARGET (TP)$0.02
STOP LOSS$0.02
RISK/REWARD1:NaN
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.85
52W High$0.18
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | $2.16M | $6.69M | $4.60M | $1.71M |
| Gross Profit | $-742,316 | $358,697 | $2.61M | $2.99M | $1.43M |
| Gross Margin | N/A | 16.6% | 39.1% | 65.0% | 83.7% |
| Operating Income | $-4,758,624 | $-7,486,442 | $-14,168,147 | $-10,266,007 | $-7,536,801 |
| Net Income | $-10,203,676 | $-9,737,464 | $-14,924,175 | $-12,169,395 | $-8,878,904 |
| Net Margin | N/A | -451.7% | -223.2% | -264.3% | -519.3% |
| EPS | $-0.17 | $-0.77 | $-4.18 | $-9.06 | $-37.68 |
Company Overview
Can B Corp. develops, manufactures, and sells cannabidiol (CBD) based products in the United States. The company provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and life style products through its Website and vending machines, and other medical professionals. It offers its products under the Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil brands. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in February 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CANBBeat Rate
0%
Last 10 quarters
Avg Surprise
-434.7%
EPS vs Estimate
Beats / Misses
0/10
Last 12 quarters
Latest EPS
$-0.05
Q4 2024
EPS Surprise History
Q2 23
-1140.0%
$-0.62vs$-0.05
Q2 23
-700.0%
$-0.36vs$0.06
Q3 23
-364.3%
$-0.37vs$0.14
Q4 23
-340.0%
$-0.36vs$0.15
Q2 24
-192.9%
$-0.13vs$0.14
Q3 24
No data
Q3 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 17, 2025 | — | — | — | — |
Q2 2025 | Jun 4, 2025 | — | — | — | — |
Q2 2025 | May 15, 2025 | — | — | — | — |
Q2 2025 | May 6, 2025 | — | — | — | — |
Q4 2024 | Nov 19, 2024 | — | $-0.05 | — | — |
Q3 2024 | Aug 19, 2024 | — | $-0.04 | — | — |
Q3 2024 | Jul 16, 2024 | — | $-0.13 | — | — |
Q2 2024 | May 20, 2024 | $0.14 | $-0.13 | -192.9% | ✗ MISS |
Q4 2023 | Nov 20, 2023 | $0.15 | $-0.36 | -340.0% | ✗ MISS |
Q3 2023 | Aug 21, 2023 | $0.14 | $-0.37 | -364.3% | ✗ MISS |
Q2 2023 | May 22, 2023 | $0.06 | $-0.36 | -700.0% | ✗ MISS |
Q2 2023 | Apr 19, 2023 | $-0.05 | $-0.62 | -1140.0% | ✗ MISS |
Q4 2022 | Nov 22, 2022 | $-0.20 | $-1.98 | -890.0% | ✗ MISS |
Q3 2022 | Aug 22, 2022 | $-0.39 | $-0.49 | -25.6% | ✗ MISS |
Q2 2022 | May 17, 2022 | $-0.27 | $-1.10 | -307.4% | ✗ MISS |
Q2 2022 | Apr 15, 2022 | $-0.77 | $-3.67 | -376.6% | ✗ MISS |
Q4 2021 | Nov 5, 2021 | $-1.50 | $-1.65 | -10.0% | ✗ MISS |
Q3 2021 | Aug 16, 2021 | — | $-1.76 | — | — |
Q2 2021 | May 21, 2021 | — | $-3.58 | — | — |
Q2 2021 | Apr 14, 2021 | — | $-7.86 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CANB
What is CANB's current stock price?
Can B Corp. (CANB) is currently trading at $0.02 per share. The stock has moved +14.29% today.
What is the analyst price target for CANB?
No analyst price targets are currently available for this stock.
What sector is Can B Corp. in?
Can B Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is CANB's market cap?
Can B Corp. has a market capitalization of $0.00 billion, making it a small-cap company.
Does CANB pay dividends?
No, Can B Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACNNF
AusCann Group Holdings Ltd
$0.00
Mkt Cap: $0.0B
CBDNF
CBD Global Sciences Inc.
$0.04
Mkt Cap: $0.0B
CIMVF
Pideka Group Inc.
$0.01
Mkt Cap: $0.0B
ETRGF
Entourage Health Corp.
$0.00
Mkt Cap: $0.0B
IWINF
Irwin Naturals Inc.
$0.50
Mkt Cap: $0.0B
KALO
Kallo Inc.
$0.00
Mkt Cap: $0.0B
PARNF
Parnell Pharmaceuticals Holdings Ltd
$0.08
Mkt Cap: $0.0B
PRXTF
Pure Extracts Technologies Corp.
$0.01
Mkt Cap: $0.0B
RCMW
RCMW Group, Inc.
$0.00
Mkt Cap: $0.0B
SILFF
Silo Wellness Inc.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to CANB for comparison